0001104659-24-033164.txt : 20240311
0001104659-24-033164.hdr.sgml : 20240311
20240311214013
ACCESSION NUMBER: 0001104659-24-033164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trizzino John
CENTRAL INDEX KEY: 0001468534
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 24740058
MAIL ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
tm248549-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-07
0
0001000694
NOVAVAX INC
NVAX
0001468534
Trizzino John
C/O NOVAVAX, INC.
700 QUINCE ORCHARD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
EVP, CCO and CBO
0
Common Stock
2024-03-07
4
M
0
28890
A
39545
D
Common Stock
2024-03-07
4
F
0
13955
5.61
D
25590
D
Restricted Stock Units
2024-03-07
4
M
0
28890
0.00
D
Common Stock
57780
0
D
Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date.
/s/ Mark J. Casey, Attorney-in-Fact
2024-03-11